BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24006437)

  • 41. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
    Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
    J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Garber AC; Shu MA; Hu J; Renne R
    J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
    Verma SC; Lan K; Choudhuri T; Robertson ES
    J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
    Cotter MA; Robertson ES
    Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visualization of a functional KSHV episome-maintenance protein LANA in living cells.
    Tetsuka T; Higuchi M; Fukushi M; Watanabe A; Takizawa S; Oie M; Gejyo F; Fujii M
    Virus Genes; 2004 Oct; 29(2):175-82. PubMed ID: 15284477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids.
    Grundhoff A; Ganem D
    J Virol; 2003 Feb; 77(4):2779-83. PubMed ID: 12552022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
    Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
    J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.
    Juillard F; de Miranda MP; Li S; Franco A; Seixas AF; Liu B; Álvarez ÁL; Tan M; Szymula A; Kaye KM; Simas JP
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22443-22451. PubMed ID: 32820070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
    Sun R; Liang D; Gao Y; Lan K
    J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
    Gupta N; Thakker S; Verma SC
    Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
    Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
    J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
    Ohsaki E; Ueda K; Sakakibara S; Do E; Yada K; Yamanishi K
    J Virol; 2004 Sep; 78(18):9936-46. PubMed ID: 15331727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.
    You J; Srinivasan V; Denis GV; Harrington WJ; Ballestas ME; Kaye KM; Howley PM
    J Virol; 2006 Sep; 80(18):8909-19. PubMed ID: 16940503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
    Lu F; Tsai K; Chen HS; Wikramasinghe P; Davuluri RV; Showe L; Domsic J; Marmorstein R; Lieberman PM
    J Virol; 2012 May; 86(10):5752-62. PubMed ID: 22419807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
    Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
    J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KSHV Genome Replication and Maintenance.
    Purushothaman P; Dabral P; Gupta N; Sarkar R; Verma SC
    Front Microbiol; 2016; 7():54. PubMed ID: 26870016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KSHV LANA--the master regulator of KSHV latency.
    Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
    Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences.
    Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M
    Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.